Skip to content

Cash ratio at other companies

PTC Therapeutics logo
PTC TherapeuticsPTCT
0.9×-1.6×
Edgewise Therapeutics, Inc. logo
Edgewise Therapeutics, Inc.EWTX
1.5×-0.9×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
0.9×+0.2×
Dyne Therapeutics, Inc. logo
Dyne Therapeutics, Inc.DYN
14.7×+0.8×
Scholar Rock logo
Scholar RockSRRK
7.2×+3.5×
Amneal Pharmaceuticals, Inc. logo
Amneal Pharmaceuticals, Inc.AMRX
0.3×+0.2×

Other financials

Income statement

See full
Revenue$149.4M+5.6%
Gross profit$134.9M+9.2%
Operating income$73.2M+15.6%
Net income$63.7M+12.3%
EPS (diluted)$0.50+11.1%

Balance sheet

See full
Cash & equivalents$755.9M+30.2%
Total debt$2.7M-13.3%
Total equity$1.0B+27.5%
Total assets$1.1B+26.3%

Cash flow

See full
Operating cash flow$59.6M-0.8%
CapEx$27.0K
Free cash flow$59.6M-0.8%

Valuation

See full
Market cap$3.84B+2.7%

Profitability

See full
Gross margin86%-0.2pp
Operating margin44.8%+1.6pp
Net margin37.1%+0.2pp
FCF margin34.9%-15.2pp

Returns & leverage

See full
Return on equity24.5%-4.6pp
Debt / equity0.0×
Current ratio7.1×+1.0×

Where this comes from

Calculated from Catalyst Pharmaceutical’s reported figures.

Based on the most recent quarter.

The official record: Catalyst Pharmaceutical’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Catalyst Pharmaceutical's cash ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Catalyst Pharmaceutical's cash ratio?
Catalyst Pharmaceutical (CPRX) reported cash ratio of 5.7× in Q1 2026.
How has Catalyst Pharmaceutical's cash ratio changed year-over-year?
Catalyst Pharmaceutical's cash ratio increased by 9.8% year-over-year, from 5.2× to 5.7×.
What is the long-term trend for Catalyst Pharmaceutical's cash ratio?
Over 5 years (2020 to 2025), Catalyst Pharmaceutical's cash ratio has grown at a -3.4% compound annual growth rate (CAGR), from 5.7× to 4.8×.
What does cash ratio mean?
Cash and equivalents divided by current liabilities at the quarter end. The most conservative liquidity measure — what the company could pay immediately with cash on hand.